BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28105937)

  • 1. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
    Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
    BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
    Xu S; Herschman HR
    Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of Gene Expression of Hexokinases in Colorectal Cancer with the Use of Bioinformatics Methods].
    Krasnov GS; Dmitriev AA; Sadtritdinova AF; Fedorova MS; Snezhkina AV; Melnikova NV; Poteryakhina AV; Nyushko KM; Belyakov MM; Kaprin AD; Zaretsky AR; Kudryavtseva AV
    Biofizika; 2015; 60(6):1050-6. PubMed ID: 26855992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
    Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
    Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion.
    Ma X; Chen J; Huang B; Fu S; Qu S; Yu R; Zhao Y
    Med Oncol; 2023 Apr; 40(5):154. PubMed ID: 37079118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition.
    Tseng PL; Chen CW; Hu KH; Cheng HC; Lin YH; Tsai WH; Cheng TJ; Wu WH; Yeh CW; Lin CC; Tsai HJ; Chang HC; Chuang JH; Shan YS; Chang WT
    Oncotarget; 2018 Apr; 9(27):18949-18969. PubMed ID: 29721175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
    Xu S; Catapang A; Braas D; Stiles L; Doh HM; Lee JT; Graeber TG; Damoiseaux R; Shirihai O; Herschman HR
    Cancer Metab; 2018; 6():7. PubMed ID: 29988332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2.
    Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; Yu W
    Aging (Albany NY); 2020 Jun; 12(12):11685-11697. PubMed ID: 32564010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.
    Garcia SN; Guedes RC; Marques MM
    Curr Med Chem; 2019; 26(41):7285-7322. PubMed ID: 30543165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1
    Xu S; Zhou T; Doh HM; Trinh KR; Catapang A; Lee JT; Braas D; Bayley NA; Yamada RE; Vasuthasawat A; Sasine JP; Timmerman JM; Larson SM; Kim Y; MacLeod AR; Morrison SL; Herschman HR
    Cancer Res; 2019 May; 79(10):2748-2760. PubMed ID: 30885978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions.
    Seiler K; Humbert M; Minder P; Mashimo I; Schläfli AM; Krauer D; Federzoni EA; Vu B; Moresco JJ; Yates JR; Sadowski MC; Radpour R; Kaufmann T; Sarry JE; Dengjel J; Tschan MP; Torbett BE
    Cell Death Dis; 2022 May; 13(5):448. PubMed ID: 35538058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
    Wolf A; Agnihotri S; Munoz D; Guha A
    Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer.
    Dai W; Meng X; Mo S; Xiang W; Xu Y; Zhang L; Wang R; Li Q; Cai G
    Cell Commun Signal; 2020 Jan; 18(1):7. PubMed ID: 31918722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.
    Wolf A; Agnihotri S; Micallef J; Mukherjee J; Sabha N; Cairns R; Hawkins C; Guha A
    J Exp Med; 2011 Feb; 208(2):313-26. PubMed ID: 21242296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermatogenic cell-specific type 1 hexokinase is the predominant hexokinase in sperm.
    Nakamura N; Shibata H; O'Brien DA; Mori C; Eddy EM
    Mol Reprod Dev; 2008 Apr; 75(4):632-40. PubMed ID: 17924400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin.
    Šimčíková D; Gardáš D; Hložková K; Hruda M; Žáček P; Rob L; Heneberg P
    Cancer Metab; 2021 Dec; 9(1):41. PubMed ID: 34895333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.
    Chen J; Zhang S; Li Y; Tang Z; Kong W
    Tumour Biol; 2014 Apr; 35(4):3743-53. PubMed ID: 24363061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus-mediated shRNA interference of ghrelin receptor blocks proliferation in the colorectal cancer cells.
    Liu A; Huang C; Xu J; Cai X
    Cancer Med; 2016 Sep; 5(9):2417-26. PubMed ID: 27464938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.
    Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y
    Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
    Liu Y; Murray-Stewart T; Casero RA; Kagiampakis I; Jin L; Zhang J; Wang H; Che Q; Tong H; Ke J; Jiang F; Wang F; Wan X
    Int J Oncol; 2017 Jun; 50(6):2011-2023. PubMed ID: 28498475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.